Editorial: Cannabidiol treatment in neurotherapeutic interventions, volume II.
作者信息
Gonzalez-Cuevas Gustavo, Navarrete Francisco, Garcia-Gutierrez Maria S, de Guglielmo Giordano, Manzanares Jorge
机构信息
Department of Clinical Psychopharmacology, College of Pharmacy, Idaho State University, Meridian, ID, United States.
Department of Psychological Science, Boise State University, Boise, ID, United States.
出版信息
Front Pharmacol. 2023 Feb 23;14:1163991. doi: 10.3389/fphar.2023.1163991. eCollection 2023.
Abstract
摘要
相似文献
1
Editorial: Cannabidiol treatment in neurotherapeutic interventions, volume II.社论：神经治疗干预中的大麻二酚治疗，第二卷。
Front Pharmacol. 2023 Feb 23;14:1163991. doi: 10.3389/fphar.2023.1163991. eCollection 2023.
2
Cannabidiol as a suggested candidate for treatment of autism spectrum disorder.大麻二酚作为自闭症谱系障碍治疗的候选药物。
Prog Neuropsychopharmacol Biol Psychiatry. 2019 Mar 8;89:90-96. doi: 10.1016/j.pnpbp.2018.08.030. Epub 2018 Aug 29.
3
Editorial: Cannabidiol Treatment in Neurotherapeutic Interventions.社论：神经治疗干预中的大麻二酚治疗
Front Pharmacol. 2021 Oct 18;12:752292. doi: 10.3389/fphar.2021.752292. eCollection 2021.
4
Effects of cannabidiol (CBD) in neuropsychiatric disorders: A review of pre-clinical and clinical findings.大麻二酚（CBD）在神经精神障碍中的作用：临床前和临床研究结果综述。
Prog Mol Biol Transl Sci. 2019;167:25-75. doi: 10.1016/bs.pmbts.2019.06.005. Epub 2019 Aug 28.
5
Cannabidiol for the treatment of autism spectrum disorder: hope or hype?大麻二酚治疗自闭症谱系障碍：希望还是炒作？
Psychopharmacology (Berl). 2022 Sep;239(9):2713-2734. doi: 10.1007/s00213-022-06196-4. Epub 2022 Jul 29.
6
Cannabidiol protects against Alzheimer's disease in C. elegans via ROS scavenging activity of its phenolic hydroxyl groups.大麻二酚通过其酚羟基的活性氧清除活性对线虫的阿尔茨海默病起到保护作用。
Eur J Pharmacol. 2022 Mar 15;919:174829. doi: 10.1016/j.ejphar.2022.174829. Epub 2022 Feb 16.
7
The therapeutic role of Cannabidiol in mental health: a systematic review.大麻二酚在心理健康中的治疗作用：一项系统综述。
J Cannabis Res. 2020 Jan 2;2(1):2. doi: 10.1186/s42238-019-0012-y.
8
Cannabidiol in Treatment of Autism Spectrum Disorder: A Case Study.大麻二酚治疗自闭症谱系障碍：一项病例研究。
Cureus. 2022 Aug 26;14(8):e28442. doi: 10.7759/cureus.28442. eCollection 2022 Aug.
9
Is cannabidiol the ideal drug to treat non-motor Parkinson's disease symptoms?大麻二酚是否是治疗非运动性帕金森病症状的理想药物？
Eur Arch Psychiatry Clin Neurosci. 2019 Feb;269(1):121-133. doi: 10.1007/s00406-019-00982-6. Epub 2019 Jan 31.
10
Is Cannabidiol During Neurodevelopment a Promising Therapy for Schizophrenia and Autism Spectrum Disorders?神经发育过程中的大麻二酚对精神分裂症和自闭症谱系障碍是一种有前景的治疗方法吗？
Front Pharmacol. 2021 Feb 4;11:635763. doi: 10.3389/fphar.2020.635763. eCollection 2020.
本文引用的文献
1
Implications of the endocannabinoid system and the therapeutic action of cannabinoids in autism spectrum disorder: A literature review.内源性大麻素系统的意义及大麻素在自闭症谱系障碍中的治疗作用：文献综述。
Pharmacol Biochem Behav. 2022 Nov;221:173492. doi: 10.1016/j.pbb.2022.173492. Epub 2022 Nov 13.
2
Cannabidiol drug interaction considerations for prescribers and pharmacists.医生和药剂师的大麻二酚药物相互作用考虑因素。
Expert Rev Clin Pharmacol. 2022 Dec;15(12):1383-1397. doi: 10.1080/17512433.2022.2142114. Epub 2022 Nov 9.
3
The role of cannabinoids in neurodevelopmental disorders of children and adolescents.大麻素在儿童和青少年神经发育障碍中的作用。
Rev Neurol. 2022 Oct 1;75(7):189-197. doi: 10.33588/rn.7507.2022123.
4
Memantine for autism spectrum disorder.美金刚治疗自闭症谱系障碍。
Cochrane Database Syst Rev. 2022 Aug 25;8(8):CD013845. doi: 10.1002/14651858.CD013845.pub2.
5
Cannabidiol for the treatment of autism spectrum disorder: hope or hype?大麻二酚治疗自闭症谱系障碍：希望还是炒作？
Psychopharmacology (Berl). 2022 Sep;239(9):2713-2734. doi: 10.1007/s00213-022-06196-4. Epub 2022 Jul 29.
6
A bibliometric analysis of the cannabis and cannabinoid research literature.大麻与大麻素研究文献的文献计量分析
J Cannabis Res. 2022 May 25;4(1):25. doi: 10.1186/s42238-022-00133-0.
7
The Autism-Psychosis Continuum Conundrum: Exploring the Role of the Endocannabinoid System.自闭症-精神病连续性难题：探索内源性大麻素系统的作用。
Int J Environ Res Public Health. 2022 May 5;19(9):5616. doi: 10.3390/ijerph19095616.
8
Autism and associated disorders: cannabis as a potential therapy.自闭症及相关障碍：大麻作为一种潜在疗法。
Front Biosci (Elite Ed). 2022 Jan 13;14(1):1. doi: 10.31083/j.fbe1401001.
9
An Update on Psychopharmacological Treatment of Autism Spectrum Disorder.自闭症谱系障碍的精神药理学治疗进展。
Neurotherapeutics. 2022 Jan;19(1):248-262. doi: 10.1007/s13311-022-01183-1. Epub 2022 Jan 14.
10
Detailing the effects of polypharmacy in psychiatry: longitudinal study of 320 patients hospitalized for depression or schizophrenia.详述精神医学中药物滥用的影响：320 例抑郁症或精神分裂症住院患者的纵向研究。
Eur Arch Psychiatry Clin Neurosci. 2022 Jun;272(4):603-619. doi: 10.1007/s00406-021-01358-5. Epub 2021 Nov 25.
Zotero 插件